The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Genetic Basis of Acute Lymphoblastic Leukemia
Open accessAbstract
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in children, it remains an important cause of morbidity and mortality in children and adults. The past decade has been marked by extraordinary advances into the genetic basis of leukemogenesis and treatment responsiveness in ALL. Both B-cell and T-cell ALL comprise multiple subtypes harboring distinct constellations of somatic structural DNA rearrangements and sequence mutations that commonly perturb lymphoid development, cytokine receptors, kinase and Ras signaling, tumor suppression, and chromatin modification. Recent studies have helped to understand the genetic basis of clonal evolution and relapse and the role of inherited genetic variants in leukemogenesis. Many of these findings are of clinical importance, and ongoing studies implementing clinical sequencing in the management of leukemia are expected to improve diagnosis, monitoring of residual disease, and early detection of relapse and to guide precise therapies. Here, we provide a concise review of genomic studies in ALL and discuss the role of genomic testing in clinical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Self-citationThe genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 1×
“PTPN11, and SH2B3); and loss-of-function mutations targeting epigenetic regulators (EZH2, SUZ12, EED, and SETD2).(52) The gene”
BackgroundSelf-citationDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
Self-citationTargetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y.-L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403088 · Cited by 1,377
Self-citationGene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Self-citationEarly T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Self-citationDen Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Self-citationAn oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Mansour, M. R., Abraham, B. J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A. D., Etchin, J., Lawton, L., Sallan, S. E., Silverman, L. B., et al. (2014) · Science · doi:10.1126/science.1259037 · Cited by 801
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 731
Self-citationRoberts, K. G., Morin, R. D., Zhang, J., Hirst, M., Zhao, Y., Su, X., Chen, S.-C., Payne-Turner, D., Churchman, M. L., Harvey, R. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.005 · Cited by 714
Self-citationCREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Self-citationRearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
Mullighan, C. G., Collins-Underwood, J. R., Phillips, L. A. A., Loudin, M. G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R. C., Willman, C. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.469 · Cited by 623
Self-citationHarvey, R. C., Mullighan, C. G., Chen, I.-M., Wharton, W., Mikhail, F. M., Carroll, A. J., Kang, H., Liu, W., Dobbin, K. K., Smith, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245944 · Cited by 574
Self-citationJAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562
Self-citationRussell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
The MLL recombinome of acute leukemias in 2013
Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., et al. (2013) · Leukemia · doi:10.1038/leu.2013.135 · Cited by 491
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
for The St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Andersson, A. K., Ma, J., Wang, J., Chen, X., Gedman, A. L., Dang, J., Nakitandwe, J., Holmfeldt, L., Parker, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3230 · Cited by 490
Self-citationRoberts, K. G., Gu, Z., Payne-Turner, D., McCastlain, K., Harvey, R. C., Chen, I.-M., Pei, D., Iacobucci, I., Valentine, M., Pounds, S. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.0073 · Cited by 453
Self-citationDeep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Faham, M., Zheng, J., Moorhead, M., Carlton, V. E. H., Stow, P., Coustan-Smith, E., Pui, C.-H., & Campana, D. (2012) · Blood · doi:10.1182/blood-2012-07-444042 · Cited by 423
Harvey, R. C., Mullighan, C. G., Wang, X., Dobbin, K. K., Davidson, G. S., Bedrick, E. J., Chen, I.-M., Atlas, S. R., Kang, H., Ar, K., et al. (2010) · Blood · doi:10.1182/blood-2009-08-239681 · Cited by 403
Self-citationPapaemmanuil, E., Rapado, I., Li, Y., Potter, N. E., Wedge, D. C., Tubio, J., Alexandrov, L. B., Van Loo, P., Cooke, S. L., Marshall, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2874 · Cited by 402
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Zhang, M. Y., Churpek, J. E., Keel, S. B., Walsh, T., Lee, M. K., Loeb, K. R., Gulsuner, S., Pritchard, C. C., Sanchez-Bonilla, M., Delrow, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3177 · Cited by 367
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
Ma, X., Edmonson, M., Yergeau, D., Muzny, D. M., Hampton, O. A., Rusch, M., Song, G., Easton, J., Harvey, R. C., Wheeler, D. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7604 · Cited by 357
Self-citationActivating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Tzoneva, G., Perez-Garcia, A., Carpenter, Z., Khiabanian, H., Tosello, V., Allegretta, M., Paietta, E., Racevskis, J., Rowe, J. M., Tallman, M. S., et al. (2013) · Nature Medicine · doi:10.1038/nm.3078 · Cited by 350
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Yoda, A., Yoda, Y., Chiaretti, S., Bar-Natan, M., Mani, K., Rodig, S. J., West, N., Xiao, Y., Brown, J. R., Mitsiades, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911726107 · Cited by 340
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
Liu, Y.-F., Wang, B.-Y., Zhang, W.-N., Huang, J.-Y., Li, B.-S., Zhang, M., Jiang, L., Li, J.-F., Wang, M.-J., Dai, Y.-J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.038 · Cited by 333
Noetzli, L., Lo, R. W., Lee-Sherick, A. B., Callaghan, M., Noris, P., Savoia, A., Rajpurkar, M., Jones, K., Gowan, K., Balduini, C. L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3253 · Cited by 331
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C., Wechsler, J., Yang, J., Hayes, J., Klein, R. J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2754 · Cited by 327
Self-citationMartinelli, G., Iacobucci, I., Storlazzi, C. T., Vignetti, M., Paoloni, F., Cilloni, D., Soverini, S., Vitale, A., Chiaretti, S., Cimino, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6408 · Cited by 317
Self-citationDeregulation of DUX4 and ERG in acute lymphoblastic leukemia
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Zhang, J., McCastlain, K., Yoshihara, H., Xu, B., Chang, Y., Churchman, M. L., Wu, G., Li, Y., Wei, L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3691 · Cited by 315
Self-citationLilljebjörn, H., Henningsson, R., Hyrenius-Wittsten, A., Olsson, L., Orsmark-Pietras, C., von Palffy, S., Askmyr, M., Rissler, M., Schrappe, M., Cario, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11790 · Cited by 314
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
He, J., Abdel-Wahab, O., Nahas, M. K., Wang, K., Rampal, R. K., Intlekofer, A. M., Patel, J., Krivstov, A., Frampton, G. M., Young, L. E., et al. (2016) · Blood · doi:10.1182/blood-2015-08-664649 · Cited by 311
Self-citationGenomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., & Downing, J. R. (2008) · Blood · doi:10.1182/blood.v112.11.429.429 · Cited by 309
Self-citationOutcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Meyer, J. A., Wang, J., Hogan, L. E., Yang, J. J., Dandekar, S., Patel, J. P., Tang, Z., Zumbo, P., Li, S., Zavadil, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2558 · Cited by 297
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Gu, Z., Churchman, M., Roberts, K., Li, Y., Liu, Y., Harvey, R. C., McCastlain, K., Reshmi, S. C., Payne-Turner, D., Iacobucci, I., et al. (2016) · Nature Communications · doi:10.1038/ncomms13331 · Cited by 290
Self-citationTargeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
Maude, S. L., Tasian, S. K., Vincent, T., Hall, J. W., Sheen, C., Roberts, K. G., Seif, A. E., Barrett, D. M., Chen, I.-M., Collins, J. R., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415448 · Cited by 289
Self-citationFusion of the Leucine Zipper Gene HLF to the E2A Gene in Human Acute B-Lineage Leukemia
Inaba, T., Roberts, W. M., Shapiro, L. H., Jolly, K. W., Raimondi, S. C., Smith, S. D., & Look, A. T. (1992) · Science · doi:10.1126/science.1386162 · Cited by 287
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Yasuda, T., Tsuzuki, S., Kawazu, M., Hayakawa, F., Kojima, S., Ueno, T., Imoto, N., Kohsaka, S., Kunita, A., Doi, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3535 · Cited by 265
Roberts, K. G., Pei, D., Campana, D., Payne-Turner, D., Li, Y., Cheng, C., Sandlund, J. T., Jeha, S., Easton, J., Becksfort, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.4105 · Cited by 256
Self-citationIrving, J., Matheson, E., Minto, L., Blair, H., Case, M., Halsey, C., Swidenbank, I., Ponthan, F., Kirschner-Schwabe, R., Groeneveld-Krentz, S., et al. (2014) · Blood · doi:10.1182/blood-2014-04-531871 · Cited by 254
Patrick, K., Wade, R., Goulden, N., Mitchell, C., Moorman, A. V., Rowntree, C., Jenkinson, S., Hough, R., & Vora, A. (2014) · British Journal of Haematology · doi:10.1111/bjh.12882 · Cited by 233
Maude, S. L., Dolai, S., Delgado-Martin, C., Vincent, T., Robbins, A., Selvanathan, A., Ryan, T., Hall, J., Wood, A. C., Tasian, S. K., et al. (2015) · Blood · doi:10.1182/blood-2014-06-580480 · Cited by 226
Self-citationCario, G., Zimmermann, M., Romey, R., Gesk, S., Vater, I., Harbott, J., Schrauder, A., Moericke, A., Izraeli, S., Akasaka, T., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256131 · Cited by 225
Iacobucci, I., Storlazzi, C. T., Cilloni, D., Lonetti, A., Ottaviani, E., Soverini, S., Astolfi, A., Chiaretti, S., Vitale, A., Messa, F., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173963 · Cited by 222
Self-citationMechanisms of clonal evolution in childhood acute lymphoblastic leukemia
Swaminathan, S., Klemm, L., Park, E., Papaemmanuil, E., Ford, A., Kweon, S.-M., Trageser, D., Hasselfeld, B., Henke, N., Mooster, J., et al. (2015) · Nature Immunology · doi:10.1038/ni.3160 · Cited by 204
The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia
Paulsson, K., Lilljebjörn, H., Biloglav, A., Olsson, L., Rissler, M., Castor, A., Barbany, G., Fogelstrand, L., Nordgren, A., Sjögren, H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3301 · Cited by 198
Roderick, J. E., Tesell, J., Shultz, L. D., Brehm, M. A., Greiner, D. L., Harris, M. H., Silverman, L. B., Sallan, S. E., Gutiérrez, A., Look, A. T., et al. (2014) · Blood · doi:10.1182/blood-2013-08-522698 · Cited by 176
Clappier, E., Mf, A., Rapion, J., Bakkus, M. H. C., Caye‐Eude, A., Khemiri, A., Giroux, C., Hernandez, L., Kabongo, E., Savola, S. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.277 · Cited by 162
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
Jeha, S., Pei, D., Raimondi, S. C., Onciu, M. M., Campana, D., Chen, C., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Howard, S. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.42 · Cited by 154
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia
Iacobucci, I., Li, Y., Roberts, K. G., Dobson, S. M., Kim, J. C., Payne-Turner, D., Harvey, R. C., Valentine, M. L., McCastlain, K., Easton, J. B., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.013 · Cited by 147
Self-citationWaibel, M., Solomon, V. S., Knight, D. A., Ralli, R., Kim, S., Banks, K.-M., Vidacs, E., Virely, C., Sia, K. C. S., Bracken, L. S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.038 · Cited by 141
Self-citationQin, H., Cho, M., Haso, W. M., Zhang, L., Tasian, S. K., Oo, H. Z., Negri, G. L., Lin, Y., Zou, J., Mallon, B. S., et al. (2015) · Blood · doi:10.1182/blood-2014-11-612903 · Cited by 133
Moorman, A. V., Robinson, H. M., Schwab, C. J., Richards, S. M., Hancock, J. P., Mitchell, C., Goulden, N., Vora, A. J., & Harrison, C. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9377 · Cited by 129
Papayannidis, C., DeAngelo, D. J., Stock, W., Huang, B., Shaik, M. N., Cesari, R., Zheng, X., Reynolds, J. M., English, P. A., Ozeck, M., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.80 · Cited by 122
Novel biological insights in T-cell acute lymphoblastic leukemia
Durinck, K., Goossens, S., Peirs, S., Wallaert, A., Loocke, W. V., Matthijssens, F., Pieters, T., Milani, G., Lammens, T., Rondou, P., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.017 · Cited by 111
Russell, L. J., Enshaei, A., Jones, L., Erhorn, A., Mašić, D., Bentley, H., Laczko, K. S., Fielding, A. K., Goldstone, A. H., Goulden, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.3242 · Cited by 96
PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia
Dang, J., Wei, L., de Ridder, J., Su, X., Rust, A. G., Roberts, K. G., Payne-Turner, D., Cheng, J., Ma, J., Qu, C., et al. (2015) · Blood · doi:10.1182/blood-2015-02-626127 · Cited by 90
Self-citationConditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300
Kino, T., Nordeen, S. K., & Chrousos, G. P. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00100-4 · Cited by 70
Lambert, J. R., & Nordeen, S. K. (2003) · Molecular Endocrinology · doi:10.1210/me.2001-0183 · Cited by 31
Wood, B. L., Winter, S. S., Dunsmore, K. P., Raetz, E. A., Borowitz, M. J., Devidas, M., Winick, N. J., Carroll, W. L., Hunger, S. P., & Loh, M. L. (2009) · Blood · doi:10.1182/blood.v114.22.9.9 · Cited by 31
Cited by
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J., Hagiwara, K., Pelletier, S., Gingras, S., Berns, H., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0315-5 · Cited by 603
Self-citationA causal mechanism for childhood acute lymphoblastic leukaemia
Greaves, M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0015-6 · Cited by 558
IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation
Park, S.-M., Cho, H., Thornton, A. M., Barlowe, T. S., Chou, T., Chhangawala, S., Fairchild, L., Taggart, J., Chow, A., Schurer, A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.016 · Cited by 97
Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia
Miyamoto, S., Urayama, K. Y., Arakawa, Y., Koh, K., Yuza, Y., Hasegawa, D., Taneyama, Y., Noguchi, Y., Yanagimachi, M., Inukai, T., et al. (2024) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2023.2201302 · Cited by 4
Metadata
- Authors
- Iacobucci, I., & Mullighan, C. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-03-20
- Volume
- 35
- Issue
- 9
- Pages
- 975-983
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2590406062
- Cited by
- 556
- References
- 66
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.